Cargando…
Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
Background: Young women with polycystic ovary syndrome (PCOS) have a high risk of developing endometrial carcinoma. There is a need for the development of new medical therapies that can reduce the need for surgical intervention so as to preserve the fertility of these patients. The aim of the study...
Autores principales: | Li, Xin, Guo, Yan-Rong, Lin, Jin-Fang, Feng, Yi, Billig, Håkan, Shao, Ruijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931265/ https://www.ncbi.nlm.nih.gov/pubmed/24563672 http://dx.doi.org/10.7150/jca.8009 |
Ejemplares similares
-
Promising clinical practices of metformin in women with PCOS and early-stage endometrial cancer
por: Shao, Ruijin, et al.
Publicado: (2014) -
Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma
por: Shao, Ruijin, et al.
Publicado: (2014) -
Endometrial progesterone resistance and PCOS
por: Li, Xin, et al.
Publicado: (2014) -
Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure
por: Liu, Yanjun, et al.
Publicado: (2023) -
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway
por: Zhang, Shun, et al.
Publicado: (2020)